HC Q study #39
See all studies
5/27
Inconc.
Late treatment study
Goldman et al., NEJM, doi:10.1056/NEJMoa2015301 (Peer Reviewed)
Remdesivir for 5 or 10 Days in Patients with Severe Covid-19
Study focused on Remdesivir but with results for HC Q in the supplementary appendix, showing 9% death with HC Q versus 12% control, RR 0.78, p = 0.46.
Source   Share   Tweet
See all studies
Please send us corrections, updates, or comments.
Submit